Grants Al some serious leverage.
Hakan's recent interview remarks may well be grounds for another lawsuit by investors.
As for Al Mann - that guy is a text-book example of how to not to manage a public company, and I use that term very loosely. Al has made one mis-step and poor decision after another for literally years, the term 'walking disaster' comes to mind.
We actually don't know if Al is mentally still anywhere near being up to the challenge. Al's last couple of appearances were only token, and his speech definitely was showing his age. I hope he is up to it, Hakan sure wasn't, and Matt, imo, just isn't impressive and is not up to the CEO position. I don't think Matt is even in the running or Al would have announced him as at least interim CEO in the press announcement. My hope is Al has retaken the reins just long enough to secure a new and this time genuinely serious partner, or a new and younger, energetic CEO.
I agree that Sanofi has damaged the franchise, but that will be really tough to prove in court, and it will be costly I suspect as well. However the threat, might be sufficient to motivate Sanofi to not fight to retain Afrezza under their control.
Expect the share price to drop to around 75 cents if Al, at this point, attempts to go it alone. Thanks to Sanofi, MNKD/Afrezza is now viewed as damaged goods.
Excellent medrsrchpro. This is another one to kept up on page one.